Azenta, Inc. (AZTA) can sell. Click on Rating Page for detail.
The price of Azenta, Inc. (AZTA) is 60.22 and it was updated on 2024-07-27 07:01:04.
Currently Azenta, Inc. (AZTA) is in undervalued.
News |
---|
New Strong Buy Stocks for July 16th
|
Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
|
Azenta to Participate in the Jefferies Global Healthcare Conference
|
Azenta (NASDAQ:AZTA) Issues FY 2024 Earnings Guidance
|
Stock Market Crash Warning: Don't Get Caught Holding These 3 Robotics Stocks
|
StockPrice Release |
---|
Azenta announces ceo succession plan
|
Azenta announces cfo transition
|
Azenta announces the acquisition of ziath
|
News |
---|
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
|
Azenta, Inc. (AZTA) Q2 2024 Earnings Call Transcript
|
Azenta Announces CEO Succession Plan
|
Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024
|
Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast
|
Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report
|
Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
|
Azenta, Inc. (AZTA) Q1 2024 Earnings Call Transcript
|
Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023
|
5 medical stocks growing earnings by triple digits
|
Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management
|
Azenta Announces Fiscal 2024 First Quarter Earnings Conference Call and Webcast
|
Azenta to Host Investor Day on March 14, 2024
|
Azenta to Participate in the 26th Annual Needham Growth Conference
|
Azenta to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
|
Final Trade: DISH, GLD, EWJ and AZTA
|
Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference
|
3 Stocks to Watch After Impressive Earnings Beats
|
Azenta, Inc. (AZTA) Q4 2023 Earnings Call Transcript
|
Azenta shares jump on Q4 results, buyback plans
|
Azenta: Life Science Play Suffers A Bad Diagnosis
|
You Can't Control Activist Investors, but You Can Control What You Do About Them
|
Activist Politan Capital engages with Azenta. Here's how the firm may boost shareholder value
|
Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
|
Azenta to Participate in the Baird 2023 Global Healthcare Conference
|
Robo-Lab Stocks: 3 Robotics Companies Changing the Research Game
|
Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential
|
Azenta: A Second Assessment
|
Azenta, Inc. (AZTA) Q2 2023 Earnings Call Transcript
|
Azenta (AZTA) Reports Q2 Loss, Misses Revenue Estimates
|
Top 5 Health Care Stocks That Could Blast Off This Month - Azenta (NASDAQ:AZTA), Amgen (NASDAQ:AMGN)
|
Azenta, Inc. (AZTA) Q1 2023 Earnings Call Transcript
|
Down -23.84% in 4 Weeks, Here's Why You Should You Buy the Dip in Brooks (AZTA)
|
Azenta (AZTA) Beats Q1 Earnings Estimates
|
Azenta Announces Fiscal 2023 First Quarter Earnings Conference Call and Webcast
|
Azenta: Excellence In Life Sciences Offerings
|
Azenta Surges To Two-Month High On $1.5 Billion Buyback Despite Covid Decline
|
Azenta, Inc. (AZTA) Q4 2022 Earnings Call Transcript
|
Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast
|
Azenta to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
|
Azenta, Inc. (AZTA) CEO Steve Schwartz on Q3 2022 Results - Earnings Call Transcript
|
Azenta (AZTA) Q3 Earnings Beat Estimates
|
Why Azenta Stock Is Tumbling Today
|
Azenta (AZTA) Beats Q2 Earnings and Revenue Estimates
|
Azenta, Inc. (AZTA) CEO Steve Schwartz on Q2 2022 Results - Earnings Call Transcript
|
All Hail the Balance Sheet Powerhouses
|
Can Brooks (AZTA) Climb 57% to Reach the Level Wall Street Analysts Expect?
|
Azenta, Inc. (AZTA) CEO Stephen Schwartz on Q1 2022 Results - Earnings Call Transcript
|
Azenta (AZTA) Beats Q1 Earnings and Revenue Estimates
|
Analysts Estimate Azenta (AZTA) to Report a Decline in Earnings: What to Look Out for
|
Brooks (AZTA) Loses 7.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
Save Your Portfolio by Getting Rid of These 4 Toxic Stocks
|
Azenta: Hyper-Focus On Life Sciences Will Unleash Growth But Wait For A Pullback
|